Education
About Us
Working with TipRanks
Follow Us
Emyria Ltd (AU:EMD)
ASX:EMD
EMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.07
Previous CloseN/A
Volume148.47K
Average Volume (3M)138.06K
Market Cap
AU$14.74M
Enterprise ValueAU$16.92M
Total Cash (Recent Filing)AU$1.97M
Total Debt (Recent Filing)AU$2.96M
Price to Earnings (P/E)―
Beta-0.62
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding491,244,170
10 Day Avg. Volume161,875
30 Day Avg. Volume138,061
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)36.12
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Emyria Ltd News
PremiumCompany Announcements
Emyria Limited Issues New Shares for Immediate Trading
PremiumCompany Announcements
Emyria Limited Updates Director’s Interest with Strategic Share Acquisition
PremiumCompany Announcements
Emyria Ltd Issues Unquoted Equity Securities for Employee Incentive
PremiumCompany Announcements
Emyria Ltd Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Emyria Ltd Successfully Passes All Resolutions at Shareholder Meeting
PremiumCompany Announcements
Emyria Issues New Shares to Boost Market Liquidity
PremiumCompany Announcements
Emyria Ltd Issues Unlisted Options to Boost Employee Engagement
PremiumCompany Announcements
Emyria Ltd Announces Quotation of New Securities on ASX---
Options Prices
Currently, No data available
---
Ownership Overview
1.63% Insiders
―
Mutual Funds
― Other Institutional Investors
98.37% Public Companies and
Individual Investors
EMD FAQ
What was Emyria Ltd’s price range in the past 12 months?
Emyria Ltd lowest share price was AU$0.03 and its highest was AU$0.07 in the past 12 months.
What is Emyria Ltd’s market cap?
Emyria Ltd’s market cap is AU$14.74M.
When is Emyria Ltd’s upcoming earnings report date?
Emyria Ltd’s upcoming earnings report date is Sep 02, 2025 which is in 150 days.
How were Emyria Ltd’s earnings last quarter?
Emyria Ltd released its earnings results on Feb 26, 2025. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Emyria Ltd overvalued?
According to Wall Street analysts Emyria Ltd’s price is currently Overvalued.
Does Emyria Ltd pay dividends?
Emyria Ltd does not currently pay dividends.
What is Emyria Ltd’s EPS estimate?
Emyria Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Emyria Ltd have?
Emyria Ltd has 491,244,170 shares outstanding.
What happened to Emyria Ltd’s price movement after its last earnings report?
Emyria Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Emyria Ltd?
Currently, no hedge funds are holding shares in AU:EMD
---
Emyria Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:EMD Sentiment 80%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth AU$1.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.15%
12-Months-Change
Fundamentals
Return on Equity
-74.80%
Trailing 12-Months
Asset Growth
-19.03%
Trailing 12-Months
Company Description
Emyria Ltd
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.
---
Technical Analysis
Biotron Limited
―
Cynata Therapeutics Limited
―
Race Oncology Ltd.
―
IDT Australia Limited
―
---